Rituxan - 50242-051-21 - (rituximab)

Alphabetical Index


Drug Information of Rituxan

Product NDC: 50242-051
Proprietary Name: Rituxan
Non Proprietary Name: rituximab
Active Ingredient(s): 10    mg/mL & nbsp;   rituximab
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Rituxan

Product NDC: 50242-051
Labeler Name: Genentech, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103705
Marketing Category: BLA
Start Marketing Date: 19971126

Package Information of Rituxan

Package NDC: 50242-051-21
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21) > 10 mL in 1 VIAL, SINGLE-USE

NDC Information of Rituxan

NDC Code 50242-051-21
Proprietary Name Rituxan
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21) > 10 mL in 1 VIAL, SINGLE-USE
Product NDC 50242-051
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rituximab
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19971126
Marketing Category Name BLA
Labeler Name Genentech, Inc.
Substance Name RITUXIMAB
Strength Number 10
Strength Unit mg/mL
Pharmaceutical Classes CD20-directed Antibody Interactions [MoA],CD20-directed Cytolytic Antibody [EPC]

Complete Information of Rituxan


General Information